The funding round is the next major step to translate iThera-MSOT technology from a tool in research to a diagnostic asset in a clinical setting, where it will be a game-changer for millions of patients worldwide.
The funding round is the next major step to translate iThera-MSOT technology from a tool in research to a diagnostic asset in a clinical setting, where it will be a game-changer for millions of patients worldwide.